American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.
Lapato DM, Roberson-Nay R, Kirkpatrick RM, et al. DNA methylation associated with postpartum depressive symptoms overlaps findings from a genome-wide association meta-analysis of depression. Clin Epigenetics. 2019;11(1):169.
Figueiredo FP, Parada AP, de Araujo LF, et al. The influence of genetic factors on peripartum depression: a systematic review. J Affect Disord. 2015;172:265–73.
Woody CA, Ferrari AJ, Siskind DJ, et al. A systematic review and meta-regression of the prevalence and incidence of PD. J Affect Disord. 2017;219:86–92.
Meltzer-Brody S, Howard LM, Bergink V, et al. Postpartum psychiatric disorders. Nat Rev Dis Primers. 2018;4:18022.
Peñalver Bernabé B, Maki PM, Dowty SM, et al. Precision medicine in PD in light of the human microbiome. Psychopharmacology. 2020;237(4):915–41.
Dagher RK, Bruckheim HE, Colpe LJ, et al. PD: Challenges and opportunities. J Womens Health (Larchmt). 2021;30(2):154–9.
Galea LAM, Frokjaer VG. PD: Embracing variability toward better treatment and outcomes. Neuron. 2019;102(1):13–6.
Serati M, Buoli M, Altamura AC. Factors that affect duration of untreated illness in pregnant women with bipolar disorder. Am J Obstet Gynecol. 2015;213(6):876.
Barkin JL, Osborne LM, Buoli M, et al. Training frontline providers in the detection and management of perinatal mood and anxiety disorders. J Womens Health (Larchmt). 2020;29(7):889–90.
Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e321–41.
Buoli M, Grassi S, Di Paolo M, et al. Is perinatal major depression affecting obstetrical outcomes? Commentary on “Impact of maternal depression on perinatal outcome in hospitalized women-a prospective study”. Arch Womens Ment Health. 2019;23(4):595–6.
Serati M, Bertino V, Malerba MR, et al. Obstetric complications and subsequent risk of mood disorders for offspring in adulthood: a comprehensive overview. Nord J Psychiatry. 2020;1–9.
Schlotz W, Phillips DI. Fetal origins of mental health: evidence and mechanisms. Brain Behav Immun. 2009;23(7):905–16.
Howard LM, Piot P, Stein A. No health without perinatal mental health. Lancet. 2014;384(9956):1723–4.
Plant DT, Pariante CM, Sharp D, Pawlby S. Maternal depression during pregnancy and offspring depression in adulthood: role of child maltreatment. Br J Psychiatry. 2015;207(3):213–20.
Viuff AC, Sharp GC, Rai D, et al. Maternal depression during pregnancy and cord blood DNA methylation: findings from the Avon Longitudinal Study of Parents and Children. Transl Psychiatry. 2018;8:244.
Goodman JH. PD and infant mental health. Arch Psychiatr Nurs. 2019;33(3):217–24.
World Health Organization. Maternal mental health and child health and development in low and middle income countries: report of the meeting, Geneva, Switzerland, 30 January–1 February, 2008.
Curry SJ, Krist AH, Owens DK, et al. US Preventive Services Task Force Interventions to Prevent PD: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(6):580–7.
Goldstein Z, Rosen B, Howlett A, et al. Interventions for paternal PD: a systematic review. J Affect Disord. 2020;265:505–10.
Bruno A, Celebre L, Mento C, et al. When fathers begin to Falter: a comprehensive review on paternal PD. Int J Environ Res Public Health. 2020;17(4):1139.
Serati M, Redaelli M, Buoli M, Altamura AC. Perinatal major depression biomarkers: a systematic review. J Affect Disord. 2016;193:391–404.
Konstantinou G, Spyropoulou A, Zervas I. Immune-inflammatory and autoimmune mechanisms in postpartum depression. Psychiatriki. 2020;31(1):47–56. Greek, Modern
Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–6.
Aronson JK, Ferner RE. Biomarkers: a general review. Curr Protoc Pharmacol. 2017;76:9.23.1–9.23.17.
Gururajan A, Clarke G, Dinan TG, Cryan JF. Molecular biomarkers of depression. Neurosci Biobehav Rev. 2016;64:101–33.
Guintivano J, Manuck T, Meltzer-Brody S. Predictors of postpartum depression: a comprehensive review of the last decade of evidence. Clin Obstet Gynecol. 2018;61(3):591–603.
Šebela A, Hanka J, Mohr P. Etiology, risk factors, and methods of postpartum depression prevention. Ceska Gynekol. 2018;83(6):468–73.
Šebela A, Hanka J, Mohr P. Diagnostics and modern trends in therapy of postpartum depression. Ceska Gynekol. 2019;84(1):68–72.
Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry. 2003;44(3):234–46.
Guintivano J, Arad M, Gould TD, et al. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry. 2014;19(5):560–7.
Pinsonneault JK, Sullivan D, Sadee W, et al. Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study. Arch Womens Ment Health. 2013;16(6):499–509.
McEvoy K, Payne JL, Osborne LM. Neuroactive steroids and PD: a review of recent literature. Curr Psychiatry Rep. 2018;20(9):78.
O'Connor TG, Tang W, Gilchrist MA, et al. Diurnal cortisol patterns and psychiatric symptoms in pregnancy: short-term longitudinal study. Biol Psychol. 2014;96:35–41.
Glynn LM, Davis EP, Sandman CA. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides. 2013;47(6):363–70.
Ferguson EH, Di Florio A, Pearson B, et al. HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression. Arch Womens Ment Health. 2017;20(3):411–20.
Zaconeta AM, Amato AA, Motta LD, Casulari LA. Relationship between placental corticotropin-releasing hormone and postpartum depression: can defining what “postpartum depression” means make a difference? Psychosom Med. 2015;77(3):342.
Parcells DA. Women's mental health nursing: depression, anxiety and stress during pregnancy. J Psychiatr Ment Health Nurs. 2010;17(9):813–20.
Buss C, Davis EP, Shahbaba B, Pruessner JC, Head K, Sandman CA. Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problems. Proc Natl Acad Sci U S A. 2012;109(20):E1312–9.
Buss C, Entringer S, Wadhwa PD. Fetal programming of brain development: intrauterine stress and susceptibility to psychopathology. Sci Signal. 2012a;5(245):pt7.
Bergink V, Gibney SM, Drexhage HA. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry. 2014;75(4):324–31.
Apter-Levy Y, Zagoory-Sharon O, Feldman R. Chronic depression alters mothers' DHEA and DEHA-to-cortisol ratio: implications for maternal behavior and child outcomes. Front Psychiatry. 2020;11:728.
Sundström Poromaa I, Comasco E, Georgakis MK, Skalkidou A. Sex differences in depression during pregnancy and the postpartum period. J Neurosci Res. 2017;95(1–2):719–30.
Osborne S, Biaggi A, Chua TE, et al. Antenatal depression programs cortisol stress reactivity in offspring through increased maternal inflammation and cortisol in pregnancy: The Psychiatry Research and Motherhood-Depression (PRAM-D) Study. Psychoneuroendocrinology. 2018;98:211–21.
Figueira P, Malloy-Diniz L, Campos SB, et al. An association study between the Val66Met polymorphism of the BDNF gene and postpartum depression. Arch Womens Ment Health. 2010;13(3):285–9.
Comasco E, Sylvén SM, Papadopoulos FC, et al. Postpartum depressive symptoms and the BDNFVal66Met functional polymorphism: effect of season of delivery. Arch Womens Ment Health. 2011;14(6):453–63.
Lommatzsch M, Hornych K, Zingler C, et al. Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology. 2006;31(3):388–94.
Pinheiro RT, Pinheiro KA, daCunha Coelho FM, et al. Brain derived neurotrophic factor levels in women with postpartum affective disorder and suicidality. Neurochem Res. 2010;37(10):2229–34.
Fung J, Gelaye B, Zhong QY, et al. Association of decreased serum brain-derived neurotrophic factor (BDNF) concentrations in early pregnancy with antepartum depression. BMC Psychiatry. 2015;15(1):43.
Mandolini GM, Lazzaretti M, Delvecchio G, et al. Association between serum BDNF levels and maternal PD: A review: special section on “Translational and Neuroscience Studies in Affective Disorders”. J Affect Disord. 2020;261:271–6. (Maria Nobile MD, PhD)
Horowitz MA, Zunszain PA. Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin. Ann N Y Acad Sci. 2015;1351:68–79.
Leff-Gelman P, Mancilla-Herrera I, Flores-Ramos M, et al. The immune system and the role of inflammation in PD. Neurosci Bull. 2016;32(4):398–420.
Simpson W, Steiner M, Coote M, Frey BN. Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study. Braz J Psychiatry. 2016;38(3):190–6.
Miller ES, Hoxha D, Pinheiro E, et al. The association of serum C-reactive protein with the occurrence and course of postpartum depression. Arch Womens Ment Health. 2019;22(1):129–32.
Cassidy-Bushrow AE, Peters RM, Johnson DA, Templin TN. Association of depressive symptoms with inflammatory biomarkers among pregnant African–American women. J Reprod Immunol. 2012;94(2):202–9.
Azar R, Mercer D. Mild depressive symptoms are associated with elevated C-reactive protein and proinflammatory cytokine levels during early to mid- gestation: a prospective pilot study. J Womens Health (Larchmt). 2013;22(4):385–9.
Buglione-Corbett R, Deligiannidis KM, Leung K, et al. Expression of inflammatory markers in women with perinatal depressive symptoms. Arch Womens Ment Health. 2018;21(6):671–9.
Miller ES, Sakowicz A, Roy A, et al. Plasma and cerebrospinal fluid inflammatory cytokines in PD. Am J Obstet Gynecol. 2019;220(3):271.e1–271.e10.
Bränn E, Edvinsson Å, Rostedt Punga A, et al. Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum. Sci Rep. 2019;9(1):1863.
Bränn E, Papadopoulos F, Fransson E, et al. Inflammatory markers in late pregnancy in association with postpartum depression: a nested case-control study. Psychoneuroendocrinology. 2017;79:146–59.
Osborne LM, Gilden J, Kamperman AM, et al. T-cell defects and postpartum depression. Brain Behav Immun. 2020;87:397–403.
Cox EQ, Stuebe A, Pearson B, et al. Oxytocin and HPA stress axis reactivity in postpartum women. Psychoneuroendocrinology. 2015;55:164–72.
Moura D, Canavarro MC, Figueiredo-Braga M. Oxytocin and depression in the perinatal period-a systematic review. Arch Womens Ment Health. 2016;19(4):561–70.
Serati M, Grassi S, Redaelli M, et al. Is there an association between oxytocin levels in plasma and pregnant women’s mental health? J Am Psychiatr Nurses Assoc. 2021;27(3):222–30.
Skrundz M, Bolten M, Nast I, et al. Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression. Neuropsychopharmacology. 2011;36(9):1886–93.
Thul TA, Corwin EJ, Carlson NS, et al. Oxytocin and postpartum depression: a systematic review. Psychoneuroendocrinology. 2020;120:104793.
Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.
Williams ME, Frey BN. Salivary cortisol during memory encoding in pregnancy predicts postpartum depressive symptoms: a longitudinal study. Trends Psychiatry Psychother. 2017;39(4):280–4.
Larqué E, Morales E, Leis R, Blanco-Carnero JE. Maternal and foetal health implications of vitamin D status during pregnancy. Ann Nutr Metab. 2018;72(3):179–92.
Cui X, Pertile R, Liu P, Eyles DW. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90–100.
Murphy PK, Mueller M, Hulsey TC, et al. An exploratory study of postpartum depression and vitamin D. J Am Psychiatr Nurses Assoc. 2010;16(3):170–7.
Cassidy-Bushrow AE, Peters RM, Johnson DA. Vitamin D nutritional status and antenatal depressive symptoms in African American women. J Womens Health (Larchmt). 2012;21:1189–95.
Brandenbarg J, Vrijkotte T, Goedhart G, VanEijsden M. Maternal early- pregnancy vitamin status is associated with maternal depressive symptoms in the Amsterdam born children and their development Cohort. Psychosom Med. 2012;74:751–7.
Gur EB, Gokduman A, Turan GA, et al. Mid pregnancy vitamin D levels and postpartum depression. Eur J Obs Gynecol Reprod Biol. 2014;179:110–6.
Robinson M, Whitehouse AJ, Newnham JP, et al. Low maternal serum vitamin during pregnancy and the risk for postpartum depression symptoms. Arch Womens Ment Health. 2014;17(3):213–9.
Miyake Y, Tanaka K, Okubo H, et al. Dietary vitamin D intake and prevalence of depressive symptoms during pregnancy in Japan. Nutrition. 2015;31(1):160–5.
Accortt EE, Schetter CD, Peters RM, Cassidy-Bushrow AE. Lower prenatal vitamin D status and postpartum depressive symptomatology in African American women: preliminary evidence for moderation by inflammatory cytokines. Arch Womens Ment Health. 2015:1–11.
Lamb AR, Lutenbacher M, Wallston KA, et al. Vitamin D deficiency and depressive symptoms in the perinatal period. Arch Womens Ment Health. 2018;21(6):745–55.
Sparling TM, Nesbitt RC, Henschke N, Gabrysch S. Nutrients and PD: a systematic review. J Nutr Sci. 2017;6:e61.
Teofilo MM, Farias DR, Pinto Tde J, et al. HDL-cholesterol concentrations are inversely associated with Edinburgh Postnatal Depression Scale scores during pregnancy: results from a Brazilian cohort study. J Psychiatr Res. 2014;58:181–8.
Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids. 2003;69(4):237–43.
Chang JP, Lin CY, Lin PY, et al. Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;80(Pt C):273–8.
Mozurkewich EL, Berman DR, Vahratian A, et al. Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines. BMC Pregnancy Childbirth. 2018;18(1):261.
Mocking RJT, Steijn K, Roos C, et al. Omega-3 fatty acid supplementation for PD: a meta-analysis. J Clin Psychiatry. 2020;81(5):19r13106.
Doornbos B, vanGoor SA, Dijck-Brouwer DA, et al. Supplementation of a low dose of DHA or DHAþAA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33(1):49–52.
Mozurkewich EL, Clinton CM, Chilimigras JL, et al. The mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. Am J Obs Gynecol. 2013;208(4):313–9.
De Giuseppe R, Roggi C, Cena H. N-3LC-PUFA supplementation: effects on infant and maternal outcomes. Eur J Nutr. 2014;53(5):1147–54.
Gene Cards. The Human Gene Database, 2020. https://www.genecards.org/.
Buoli M, Serati M, Grassi S, et al. The role of clock genes in the etiology of major depressive disorder. J Affect Disord. 2018;234:351–7.
Buoli M, Grassi S, Iodice S, et al. The role of clock genes in perinatal depression: the light in the darkness. Acta Psychiatr Scand. 2019;140(4):382–4.
Li JZ, Bunney BG, Meng F, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A. 2013;110:9950–5.
Tabano S, Caldiroli A, Terrasi A, et al. A miRNome analysis of drug-free manic psychotic bipolar patients versus healthy controls. Eur Arch Psychiatry Clin Neurosci. 2019;270(7):893–900.
Bierer LM, Bader HN, Daskalakis NP, et al. Intergenerational effects of maternal holocaust exposure on FKBP5 methylation. Am J Psychiatry. 2020;177(8):744–53.
King L, Robins S, Chen G, et al. Perinatal depression and DNA methylation of oxytocin-related genes: a study of mothers and their children. Horm Behav. 2017;96:84–94.
Feldman R, Weller A, Zagoory-Sharon O, Levine A. Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding. Psychol Sci. 2007;18:965–70.
Roy B, Yoshino Y, Allen L, et al. Exploiting circulating microRNAs as biomarkers in psychiatric disorders. Mol Diagn Ther. 2020;24(3):279–98.
Carnevali GS, Buoli M. The role of epigenetics in PD: are there any candidate biomarkers? J Affect Disord. 2021;280(Pt B):57–67.
Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800–19.
Pariante CM. Depression during pregnancy: molecular regulations of mothers’ and children’s behaviour. Biochem Soc Trans. 2014;42(2):582–6.
Biaggi A, Conroy S, Pawlby S, Pariante CM. Identifying the women at risk of antenatal anxiety and depression: a systematic review. J Affect Disord. 2016;191:62–77.